CLINICAL_TRIALS
trial_result
· 2023-03-10
Clinical Trial Update: ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) [Phase 3]
Summary
Phase 3 trial ESSENCE 2 evaluating CyclASol for dry eye disease has completed and results were posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novaliq GmbH | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-03-10